Zobrazeno 1 - 3
of 3
pro vyhledávání: '"P. V. Мazin"'
Publikováno v:
Фармакоэкономика, Vol 10, Iss 1, Pp 29-38 (2017)
Perampanel (PER) is a novel drug for treatment of refractory partial epilepsy in patients≥12 y.o. with proven efficacy and safety. PER is registered and may also be used successfully as adjunctive treatment in therapy of primary generalized tonic-c
Externí odkaz:
https://doaj.org/article/3e7cb4e5b3be4fc5b4480ce5ec0deb9a
Publikováno v:
Фармакоэкономика, Vol 10, Iss 1, Pp 11-18 (2017)
Innovative drugs eribulin and trabectedin are effective in the treatment of soft tissue sarcomas (STS) – rare, but severe malignancies.Aim of the study. To perform the pharmacoeconomic evaluation of these two agents used with the second and subsequ
Externí odkaz:
https://doaj.org/article/220858efa1d94f5aae765073fbdb6eea
Publikováno v:
Фармакоэкономика, Vol 10, Iss 1, Pp 29-38 (2017)
Perampanel (PER) is a novel drug for treatment of refractory partial epilepsy in patients≥12 y.o. with proven efficacy and safety. PER is registered and may also be used successfully as adjunctive treatment in therapy of primary generalized tonic-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b43c505e16b1cb576ae61567638358fb
https://doi.org/10.17749/2070-4909.2017.10.1.029-038
https://doi.org/10.17749/2070-4909.2017.10.1.029-038